CA2176259A1 - Composes oligonucleosidiques chimeriques - Google Patents
Composes oligonucleosidiques chimeriquesInfo
- Publication number
- CA2176259A1 CA2176259A1 CA002176259A CA2176259A CA2176259A1 CA 2176259 A1 CA2176259 A1 CA 2176259A1 CA 002176259 A CA002176259 A CA 002176259A CA 2176259 A CA2176259 A CA 2176259A CA 2176259 A1 CA2176259 A1 CA 2176259A1
- Authority
- CA
- Canada
- Prior art keywords
- rnaseh
- linkage
- compound
- linkages
- activating region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composés oligonucléosidiques chimériques et leurs procédés de préparation et de formulation. Ces composés et compositions sont utilisables dans l'activation du clivage à médiation par RNaseH des séquences cibles d'acide ribonucléique, et dans le traitement des états pathologiques associés à ces séquences.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15401493A | 1993-11-16 | 1993-11-16 | |
US15401393A | 1993-11-16 | 1993-11-16 | |
US08/154,014 | 1993-11-16 | ||
US08/154,013 | 1993-11-16 | ||
US08/223,778 | 1994-04-06 | ||
US23377894A | 1994-04-26 | 1994-04-26 | |
US23817794A | 1994-05-04 | 1994-05-04 | |
US08/238,177 | 1994-05-04 | ||
PCT/US1994/013387 WO1995013834A1 (fr) | 1993-11-16 | 1994-11-16 | Composes oligonucleosidiques chimeriques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2176259A1 true CA2176259A1 (fr) | 1995-05-26 |
Family
ID=27496113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002176259A Abandoned CA2176259A1 (fr) | 1993-11-16 | 1994-11-16 | Composes oligonucleosidiques chimeriques |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0743859A4 (fr) |
JP (1) | JPH09506248A (fr) |
KR (1) | KR960705589A (fr) |
AU (1) | AU689182B2 (fr) |
CA (1) | CA2176259A1 (fr) |
IL (1) | IL111660A (fr) |
NZ (1) | NZ277617A (fr) |
WO (1) | WO1995013834A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996031600A1 (fr) * | 1995-04-03 | 1996-10-10 | Hybridon, Inc. | Procede de modulation de l'expression genique sans depletion de complement |
US6509149B2 (en) * | 1995-06-06 | 2003-01-21 | Hybridon, Inc. | HPV-specific oligonucleotides |
US5898031A (en) * | 1996-06-06 | 1999-04-27 | Isis Pharmaceuticals, Inc. | Oligoribonucleotides for cleaving RNA |
US20010049436A1 (en) * | 1998-04-01 | 2001-12-06 | Wen-Qiang Zhou | Mixed-backbone oligonucleotides containing pops blocks to obtain reduced phosphorothioate content |
US6277967B1 (en) | 1998-07-14 | 2001-08-21 | Isis Pharmaceuticals, Inc. | Carbohydrate or 2′-modified oligonucleotides having alternating internucleoside linkages |
ES2336887T5 (es) | 2000-03-30 | 2019-03-06 | Whitehead Inst Biomedical Res | Mediadores de interferencia por ARN específicos de secuencias de ARN |
ES2500923T3 (es) † | 2000-03-30 | 2014-10-01 | The Whitehead Institute For Biomedical Research | Mediadores específicos de secuencia de ARN de interferencia de ARN |
EP1873259B1 (fr) | 2000-12-01 | 2012-01-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Interférence ARN à médiation par ARN 21 et 22nt |
EP1527176B2 (fr) | 2002-08-05 | 2017-03-22 | Silence Therapeutics GmbH | Nouvelles formes de molecules d'arn interferant |
ES2695050T3 (es) * | 2002-08-05 | 2018-12-28 | Silence Therapeutics Gmbh | Nuevas formas adicionales de moléculas de ARN de interferencia |
US9827263B2 (en) | 2002-11-05 | 2017-11-28 | Ionis Pharmaceuticals, Inc. | 2′-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
US9150605B2 (en) | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation |
US9150606B2 (en) | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
EP2742136B1 (fr) * | 2011-08-11 | 2017-09-27 | Ionis Pharmaceuticals, Inc. | Composés oligomères à brèche comprenant des désoxyribonucléosides modifiés en 5' dans la brèche, et leurs utilisations |
JP7128517B2 (ja) * | 2016-09-14 | 2022-08-31 | レナセラピューティクス株式会社 | 副作用を減じたアンチセンス核酸 |
CA3151789A1 (fr) * | 2019-09-19 | 2021-03-25 | Arnay Sciences, Llc | Composes et procedes utiles pour moduler l'epissage de genes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212295A (en) * | 1990-01-11 | 1993-05-18 | Isis Pharmaceuticals | Monomers for preparation of oligonucleotides having chiral phosphorus linkages |
US5149797A (en) * | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
DK1695979T3 (da) * | 1991-12-24 | 2011-10-10 | Isis Pharmaceuticals Inc | Gappede modificerede oligonukleotider |
-
1994
- 1994-11-16 WO PCT/US1994/013387 patent/WO1995013834A1/fr not_active Application Discontinuation
- 1994-11-16 IL IL11166094A patent/IL111660A/xx not_active IP Right Cessation
- 1994-11-16 CA CA002176259A patent/CA2176259A1/fr not_active Abandoned
- 1994-11-16 KR KR1019960702552A patent/KR960705589A/ko not_active Application Discontinuation
- 1994-11-16 JP JP7514646A patent/JPH09506248A/ja active Pending
- 1994-11-16 EP EP95904098A patent/EP0743859A4/fr not_active Withdrawn
- 1994-11-16 NZ NZ277617A patent/NZ277617A/en unknown
- 1994-11-16 AU AU12916/95A patent/AU689182B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0743859A4 (fr) | 1998-10-21 |
IL111660A (en) | 2005-05-17 |
IL111660A0 (en) | 1995-01-24 |
KR960705589A (ko) | 1996-11-08 |
NZ277617A (en) | 1998-01-26 |
AU1291695A (en) | 1995-06-06 |
AU689182B2 (en) | 1998-03-26 |
EP0743859A1 (fr) | 1996-11-27 |
JPH09506248A (ja) | 1997-06-24 |
WO1995013834A1 (fr) | 1995-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6060456A (en) | Chimeric oligonucleoside compounds | |
AU2003202376B2 (en) | Oligonucleotides comprising alternating segments and uses thereof | |
US6028188A (en) | Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages | |
US5986083A (en) | Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages | |
US6015886A (en) | Oligonucleotide phosphate esters | |
AU678769B2 (en) | Oligonucleotide alkylphosphonothioates | |
AU2003202376A1 (en) | Oligonucleotides comprising alternating segments and uses thereof | |
US20030083477A1 (en) | Three component chimeric antisense oligonucleotides | |
CA2176259A1 (fr) | Composes oligonucleosidiques chimeriques | |
JPH06511155A (ja) | ギャップを有する2′修飾オリゴヌクレオチド | |
Miller | Non-ionic antisense oligonucleotides | |
US8178348B2 (en) | Chimeric antisense oligonucleotides of arabinofuranose analogue and deoxyribose nucleotides | |
JPH07508657A (ja) | ras遺伝子のアンチセンスオリゴヌクレオチドによる阻害 | |
Noe et al. | Chemistry of antisense oligonucleotides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |